Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1988 2
1989 1
1992 1
1993 1
1995 1
1996 1
1998 1
1999 3
2000 1
2001 1
2002 1
2003 2
2004 4
2005 1
2006 4
2007 3
2008 7
2009 4
2010 4
2011 7
2012 6
2013 5
2014 11
2015 11
2016 10
2017 15
2018 8
2019 13
2020 14
2021 17
2022 19
2023 20
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Oaknin A, Gladieff L, Martínez-García J, Villacampa G, Takekuma M, De Giorgi U, Lindemann K, Woelber L, Colombo N, Duska L, Leary A, Godoy-Ortiz A, Nishio S, Angelergues A, Rubio MJ, Fariñas-Madrid L, Yamaguchi S, Lorusso D, Ray-Coquard I, Manso L, Joly F, Alarcón J, Follana P, Romero I, Lebreton C, Pérez-Fidalgo JA, Yunokawa M, Dahlstrand H, D'Hondt V, Randall LM; ENGOT-Cx10–GEICO 68-C–JGOG1084–GOG-3030 Investigators. Oaknin A, et al. Among authors: martinez garcia j. Lancet. 2024 Jan 6;403(10421):31-43. doi: 10.1016/S0140-6736(23)02405-4. Epub 2023 Dec 1. Lancet. 2024. PMID: 38048793 Clinical Trial.
Case Studies.
Álvarez-Buylla Roces ME, Martínez-García JC, Dávila-Velderrain J, Domínguez-Hüttinger E, Martínez-Sánchez ME. Álvarez-Buylla Roces ME, et al. Among authors: martinez garcia jc. Adv Exp Med Biol. 2018;1069:135-209. doi: 10.1007/978-3-319-89354-9_3. Adv Exp Med Biol. 2018. PMID: 30076567
Modeling Procedures.
Álvarez-Buylla Roces ME, Martínez-García JC, Dávila-Velderrain J, Domínguez-Hüttinger E, Martínez-Sánchez ME. Álvarez-Buylla Roces ME, et al. Among authors: martinez garcia jc. Adv Exp Med Biol. 2018;1069:35-134. doi: 10.1007/978-3-319-89354-9_2. Adv Exp Med Biol. 2018. PMID: 30076566 Review.
Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis.
Millet V, Gensollen T, Maltese M, Serrero M, Lesavre N, Bourges C, Pitaval C, Cadra S, Chasson L, Vu Man TP, Masse M, Martinez-Garcia JJ, Tranchida F, Shintu L, Mostert K, Strauss E, Lepage P, Chamaillard M, Broggi A, Peyrin-Biroulet L, Grimaud JC, Naquet P, Galland F. Millet V, et al. Among authors: martinez garcia jj. Gut. 2023 Jun;72(6):1115-1128. doi: 10.1136/gutjnl-2021-325792. Epub 2022 Sep 29. Gut. 2023. PMID: 36175116
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.
Kurtz JE, Pujade-Lauraine E, Oaknin A, Belin L, Leitner K, Cibula D, Denys H, Rosengarten O, Rodrigues M, de Gregorio N, Martinez García J, Petru E, Kocián R, Vergote I, Pautier P, Schmalfeldt B, Gaba L, Polterauer S, Mouret Reynier MA, Sehouli J, Churruca C, Selle F, Joly F, D'Hondt V, Bultot-Boissier É, Lebreton C, Lotz JP, Largillier R, Heudel PE, Heitz F; ATALANTE/ENGOT-ov29 Investigators. Kurtz JE, et al. Among authors: martinez garcia j. J Clin Oncol. 2023 Oct 20;41(30):4768-4778. doi: 10.1200/JCO.23.00529. Epub 2023 Aug 29. J Clin Oncol. 2023. PMID: 37643382 Free PMC article. Clinical Trial.
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.
Vergote I, Pérez-Fidalgo JA, Hamilton EP, Valabrega G, Van Gorp T, Sehouli J, Cibula D, Levy T, Welch S, Richardson DL, Guerra EM, Scambia G, Henry S, Wimberger P, Miller DS, Klat J, Martínez-Garcia J, Raspagliesi F, Pothuri B, Romero I, Bergamini A, Slomovitz B, Schochter F, Høgdall E, Fariñas-Madrid L, Monk BJ, Michel D, Kauffman MG, Shacham S, Mirza MR, Makker V; ENGOT-EN5/GOG-3055/SIENDO Investigators. Vergote I, et al. Among authors: martinez garcia j. J Clin Oncol. 2023 Dec 10;41(35):5400-5410. doi: 10.1200/JCO.22.02906. Epub 2023 Sep 5. J Clin Oncol. 2023. PMID: 37669480 Clinical Trial.
Medical Systems Biology.
Álvarez-Buylla Roces ME, Martínez-García JC, Dávila-Velderrain J, Domínguez-Hüttinger E, Martínez-Sánchez ME. Álvarez-Buylla Roces ME, et al. Among authors: martinez garcia jc. Adv Exp Med Biol. 2018;1069:1-33. doi: 10.1007/978-3-319-89354-9_1. Adv Exp Med Biol. 2018. PMID: 30076565
Magnetic Lateral Flow Immunoassays.
Moyano A, Serrano-Pertierra E, Salvador M, Martínez-García JC, Rivas M, Blanco-López MC. Moyano A, et al. Among authors: martinez garcia jc. Diagnostics (Basel). 2020 May 8;10(5):288. doi: 10.3390/diagnostics10050288. Diagnostics (Basel). 2020. PMID: 32397264 Free PMC article. Review.
Molecular mechanisms of shade tolerance in plants.
Martinez-Garcia JF, Rodriguez-Concepcion M. Martinez-Garcia JF, et al. New Phytol. 2023 Aug;239(4):1190-1202. doi: 10.1111/nph.19047. Epub 2023 Jun 6. New Phytol. 2023. PMID: 37282777 Review.
Gene Therapy for Acquired and Genetic Cholestasis.
Martínez-García J, Molina A, González-Aseguinolaza G, Weber ND, Smerdou C. Martínez-García J, et al. Biomedicines. 2022 May 26;10(6):1238. doi: 10.3390/biomedicines10061238. Biomedicines. 2022. PMID: 35740260 Free PMC article. Review.
197 results